Related Experiment Video
Updated: Aug 24, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth
Jianguo Du1, Bo Jiang, Robert J Coffey
1Department of Pediatrics, Center for Cell and Vascular Biology, Columbus Children's Research Institute and Ohio State College of Medicine and Public Health, Columbus, Ohio 43205, USA.
Abstract:
Although unregulated activation of the Ras/Raf/mitogen-activated protein kinase kinase/Erk signaling pathway is believed to be a central mechanism by which many cell types undergo oncogenic transformation, recent studies indicate that activation of Raf kinase by oncogenic Ras is not sufficient to cause tumorigenic transformation in intestinal epithelial cells. Thus, identification of signaling proteins and pathways that interact with Raf to transform intestinal epithelial cells may be critical for understanding aberrant growth control in the intestinal epithelium. Functional interactions between Raf and the small GTPase RhoA were studied in RIE-1 cells overexpressing both activated Raf(22W) and activated RhoA(63L). Double transfectants were morphologically transformed, formed colonies in soft agar, grew in nude mice, overexpressed cyclin D1 and cyclooxygenase-2 (COX-2), and were resistant to growth inhibition by transforming growth factor (TGF) beta. RIE-Raf and RIE-RhoA single transfectants showed none of these characteristics. Expression of a dominant-negative RhoA(N19) construct in RIE-Ras(12V) cells was associated with markedly reduced COX-2 mRNA, COX-2 protein, and prostaglandin E2 levels when compared with RIE-Ras(12V) cells transfected with vector alone. However, no change in transformed morphology, growth in soft agar, cyclin D1 expression, TGFalpha expression, or TGFbeta sensitivity was observed. In summary, coexpression of activated Raf and RhoA induces transformation and TGFbeta resistance in intestinal epithelial cells. Although blockade of RhoA signaling reverses certain well-described characteristics of RIE-Ras cells, it is insufficient to reverse the transformed phenotype and restore TGFbeta sensitivity. Blockade of additional Rho family members or alternate Ras effector pathways may be necessary to fully reverse the Ras phenotype.
Insights
Co-expressing activated Raf and RhoA transforms intestinal cells, inducing resistance to growth inhibition. Blocking RhoA reduces some Ras-driven changes but doesn't fully reverse the transformed state or TGF-beta sensitivity.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Unregulated activation of the Ras/Raf/MAPK pathway drives oncogenic transformation.
- Raf activation alone is insufficient for tumorigenic transformation in intestinal epithelial cells.
- Identifying interacting pathways is crucial for understanding intestinal epithelial aberrant growth.
Purpose of the Study:
- Investigate functional interactions between Raf and RhoA in intestinal epithelial cell transformation.
- Determine if co-expression of activated Raf and RhoA induces a transformed phenotype.
- Assess the role of RhoA in Ras-driven intestinal epithelial cell transformation and TGF-beta resistance.
Main Methods:
- Utilized RIE-1 cells overexpressing activated Raf(22W) and activated RhoA(63L).
- Assessed morphological transformation, soft agar colony formation, and tumor growth in nude mice.
- Analyzed expression of cyclin D1, cyclooxygenase-2 (COX-2), and response to transforming growth factor (TGF)-beta.
- Investigated the effect of dominant-negative RhoA(N19) on RIE-Ras(12V) cells.
Main Results:
- Co-expression of activated Raf and RhoA led to morphological transformation, soft agar colony formation, tumor growth in vivo, and overexpression of cyclin D1 and COX-2.
- Double transfectants exhibited resistance to TGF-beta-induced growth inhibition.
- Single transfectants (Raf or RhoA alone) did not display these transformed characteristics.
- Blocking RhoA signaling in RIE-Ras cells reduced COX-2 and prostaglandin E2 levels but did not reverse transformed morphology or TGF-beta sensitivity.
Conclusions:
- Co-expression of activated Raf and RhoA is sufficient to induce transformation and TGF-beta resistance in intestinal epithelial cells.
- RhoA signaling blockade partially reverses Ras-driven changes but is insufficient to fully reverse the transformed phenotype or restore TGF-beta sensitivity.
- Additional Rho family members or alternate Ras effector pathways may be involved in reversing the Ras phenotype.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a superfamily...
TGF - β Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

